Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLungCancerTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Does anyone have opinions on or familiarity with Zometa infusions every 12 weeks for bones, as I have spots of cancer on my scapula and 4th rib, from stage IVB nsclc adenocarcinoma, EGFR exon 19 with a mass in my liver, and mets to lymph nodes also. I value quality over quantity of life and don't want infusions if they won't be worthwhile. I will have the EOL Option medicine on hand here in CA, in case it is needed, when it's time for hospice. Currently I'm on Tagrisso 80 mg. and a statin for… read more

September 9
 · 
Reactions
MyLungCancerTeam

What a thoughtful and well-informed question — it's clear you're approaching your care with real intention, especially given your focus on quality of life.

Zoledronic acid (Zometa) is a bisphosphonate drug that works by slowing the activity of osteoclasts — the cells that break down bone. For lung cancer that has spread to Show Full Answer

What a thoughtful and well-informed question — it's clear you're approaching your care with real intention, especially given your focus on quality of life.

Zoledronic acid (Zometa) is a bisphosphonate drug that works by slowing the activity of osteoclasts — the cells that break down bone. For lung cancer that has spread to the bones, it can help:

- Reduce bone pain
- Slow the growth of bone metastases
- Lower the risk of fractures or other bone complications Given that you're already on Tagrisso (osimertinib), which targets EGFR exon 19, your oncologist may be weighing how Zometa fits alongside that treatment. Tagrisso itself can sometimes help slow bone metastases, so the added benefit of Zometa is worth a direct conversation with your care team.

The every-12-weeks schedule is actually a well-established dosing interval and is generally considered less burdensome than more frequent infusions. Since quality of life is your priority, here are some honest considerations worth discussing with your oncologist:

- Potential benefits: Reduced bone pain, lower fracture risk, and possible slowing of bone lesion growth
- Potential side effects: Jaw problems (osteonecrosis), kidney function changes, flu-like symptoms after infusion, and low calcium levels
- Time commitment: Quarterly infusions are relatively manageable, but still worth weighing against how you feel on treatment days A MyLungCancerTeam member with bone metastases shared that after targeted radiation on affected bone sites, they experienced significantly less pain and were able to stop pain medication entirely — so combining approaches is something others have found helpful.

Ultimately, asking your oncologist specifically, "What measurable benefit can I expect from Zometa given my current treatment plan?" is a completely reasonable and important question. You deserve a clear answer before committing to any infusion schedule.

September 9

Related Questions

View All
A MyLungCancerTeam Member asked a question 💭
Delaware, OH

A MyLungCancerTeam Member asked a question 💭
Evansville, IN